{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:19:45Z","timestamp":1790651985382,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.neurol.2025.01.002","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T14:36:46Z","timestamp":1738334206000},"page":"217-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Retrospective, descriptive study of acute myelitis in French Guyana"],"prefix":"10.1016","volume":"181","author":[{"given":"P.","family":"Grimont","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Montcuquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Quet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"De Toffol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Deschamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.neurol.2025.01.002_bib0180","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1212\/WNL.59.4.499","article-title":"Proposed diagnostic criteria and nosology of acute transverse myelitis","volume":"59","year":"2002","journal-title":"Neurology"},{"issue":"02","key":"10.1016\/j.neurol.2025.01.002_bib0185","doi-asserted-by":"crossref","first-page":"097","DOI":"10.1055\/s-0032-1322586","article-title":"Acute transverse myelitis: demyelinating, inflammatory, and infectious myelopathies","volume":"32","author":"West","year":"2012","journal-title":"Semin Neurol"},{"issue":"4","key":"10.1016\/j.neurol.2025.01.002_bib0190","doi-asserted-by":"crossref","first-page":"e414","DOI":"10.1212\/WNL.0000000000007828","article-title":"Aquaporin-4 and MOG autoantibody discovery in idiopathic transverse myelitis epidemiology","volume":"93","author":"Sechi","year":"2019","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.neurol.2025.01.002_bib0195","doi-asserted-by":"crossref","first-page":"e1071","DOI":"10.1212\/NXI.0000000000001071","article-title":"Modern look at transverse myelitis and inflammatory myelopathy: epidemiology of the National Veterans Health administration population","volume":"8","author":"Abbatemarco","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"issue":"7\u20138","key":"10.1016\/j.neurol.2025.01.002_bib0200","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.neurol.2019.07.001","article-title":"Infectious myelitis","volume":"175","author":"Lebrun Frenay","year":"2019","journal-title":"Rev Neurol (Paris)"},{"issue":"2","key":"10.1016\/j.neurol.2025.01.002_bib0205","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1212\/WNL.0000000000004796","article-title":"Evaluation of idiopathic transverse myelitis revealing specific myelopathy diagnoses","volume":"90","author":"Zalewski","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2025.01.002_bib0210","doi-asserted-by":"crossref","first-page":"993645","DOI":"10.3389\/fneur.2022.993645","article-title":"Neuroimaging features in inflammatory myelopathies: a review","volume":"13","author":"Cacciaguerra","year":"2022","journal-title":"Front Neurol"},{"key":"10.1016\/j.neurol.2025.01.002_bib0215","series-title":"Handbook of clinical neurology [Internet]","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-444-52001-2.00027-3","article-title":"Acute inflammatory myelopathies","author":"Cree","year":"2014"},{"issue":"6","key":"10.1016\/j.neurol.2025.01.002_bib0220","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s00415-009-5058-x","article-title":"Long-term outcome of acute and subacute myelopathies","volume":"256","author":"Debette","year":"2009","journal-title":"J Neurol"},{"issue":"2\u20133","key":"10.1016\/j.neurol.2025.01.002_bib0225","first-page":"43","article-title":"L\u2019infection VIH en Guyane\u00a0: revue historique et tendances actuelles [HIV in French Guiana: historical review and current trends]","author":"Nacher","year":"2020","journal-title":"Bull Epidemiol Hebd"},{"issue":"4","key":"10.1016\/j.neurol.2025.01.002_bib0230","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3390\/tropicalmed8040219","article-title":"The epidemiologic transition in French Guiana: secular trends and setbacks, and comparisons with continental France and South American Countries","volume":"8","author":"Nacher","year":"2023","journal-title":"Trop Med Infect Dis"},{"key":"10.1016\/j.neurol.2025.01.002_bib0235","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3389\/fneur.2020.00501","article-title":"Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide","volume":"11","author":"Hor","year":"2020","journal-title":"Front Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2025.01.002_bib0240","article-title":"Epidemiology of neuromyelitis optica in Latin America","volume":"3","author":"Alvarenga","year":"2017","journal-title":"Mult Scler J Exp Transl Clin"},{"issue":"8\u20139","key":"10.1016\/j.neurol.2025.01.002_bib0245","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.neurol.2009.02.012","article-title":"\u00c9pid\u00e9miologie descriptive de la neuromy\u00e9lite optique dans le bassin cara\u00efb\u00e9en","volume":"165","author":"Cabre","year":"2009","journal-title":"Rev Neurol (Paris)"},{"issue":"6","key":"10.1016\/j.neurol.2025.01.002_bib0250","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1007\/s10072-023-06617-y","article-title":"Worldwide prevalence of neuromyelitis optica spectrum disorder (NMOSD) and neuromyelitis optica (NMO): a systematic review and meta-analysis","volume":"44","author":"Bagherieh","year":"2023","journal-title":"Neurol Sci"},{"issue":"11","key":"10.1016\/j.neurol.2025.01.002_bib0255","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1212\/WNL.0000000000001367","article-title":"MRI characteristics of neuromyelitis optica spectrum disorder: an international update","volume":"84","author":"Kim","year":"2015","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neurol.2025.01.002_bib0260","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neurol.2025.01.002_bib0265","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2025.01.002_bib0270","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2025.01.002_bib0275","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.nrl.0000149975.39201.0b","article-title":"Diagnosis and management of acute myelopathies","volume":"11","author":"Kaplin","year":"2005","journal-title":"Neurologist"},{"key":"10.1016\/j.neurol.2025.01.002_bib0280","doi-asserted-by":"crossref","first-page":"1011579","DOI":"10.3389\/fneur.2022.1011579","article-title":"Myelitis features and outcomes in CNS demyelinating disorders: comparison between multiple sclerosis, MOGAD, and AQP4-IgG-positive NMOSD","volume":"13","author":"Fadda","year":"2022","journal-title":"Front Neurol"},{"issue":"2","key":"10.1016\/j.neurol.2025.01.002_bib0285","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00281-018-0723-8","article-title":"Sex differences in autoimmune disorders of the central nervous system","volume":"41","author":"Gold","year":"2019","journal-title":"Semin Immunopathol"},{"issue":"2","key":"10.1016\/j.neurol.2025.01.002_bib0290","first-page":"7","article-title":"Acute transverse myelitis in children, literature review","volume":"12","author":"Tavasoli","year":"2018","journal-title":"Iran J Child Neurol"},{"issue":"9_Supplement_2","key":"10.1016\/j.neurol.2025.01.002_bib0295","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1212\/WNL.0000000000002820","article-title":"Pediatric transverse myelitis","volume":"87","author":"Absoud","year":"2016","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.neurol.2025.01.002_bib0300","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/jamaneurol.2013.5857","article-title":"Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study","volume":"71","author":"Kitley","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2025.01.002_bib0305","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1260358","article-title":"Epidemiology of myelin oligodendrocyte glycoprotein antibody-associated disease: a review of prevalence and incidence worldwide","volume":"14","author":"Hor","year":"2023","journal-title":"Front Neurol"},{"issue":"5","key":"10.1016\/j.neurol.2025.01.002_bib0310","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/ana.24617","article-title":"Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum: aquaporin-4-IgG seroprevalence","volume":"79","author":"Flanagan","year":"2016","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.neurol.2025.01.002_bib0315","doi-asserted-by":"crossref","first-page":"e1089","DOI":"10.1212\/NXI.0000000000001089","article-title":"Neuromyelitis optica spectrum disorders in Africa: a systematic review","volume":"8","author":"Musubire","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"10.1016\/j.neurol.2025.01.002_bib0320","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41572-020-0214-9","article-title":"Neuromyelitis optica","volume":"6","author":"Jarius","year":"2020","journal-title":"Nat Rev Dis Primer"},{"issue":"7","key":"10.1016\/j.neurol.2025.01.002_bib0325","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1007\/s00415-023-11634-0","article-title":"Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD)\u00a0\u2013\u00a0revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: diagnosis and differential diagnosis","volume":"270","author":"Jarius","year":"2023","journal-title":"J Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2025.01.002_bib0330","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/cei.13630","article-title":"Magnetic resonance imaging in neuromyelitis optica spectrum disorder","volume":"206","author":"Clarke","year":"2021","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.neurol.2025.01.002_bib0335","doi-asserted-by":"crossref","first-page":"e308","DOI":"10.1212\/WNL.0000000000201465","article-title":"Differentiating multiple sclerosis from AQP4-neuromyelitis optica spectrum disorder and MOG-antibody disease with imaging","volume":"100","author":"Cortese","year":"2023","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neurol.2025.01.002_bib0340","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1212\/WNL.0000000000011153","article-title":"Worldwide incidence and prevalence of NMO: a systematic review","volume":"96","author":"Papp","year":"2021","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.neurol.2025.01.002_bib0345","doi-asserted-by":"crossref","first-page":"e107274","DOI":"10.1371\/journal.pone.0107274","article-title":"Low levels of vitamin D in neuromyelitis optica spectrum disorder: association with disease disability","volume":"9","author":"Min","year":"2014","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.neurol.2025.01.002_bib0350","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.3390\/nu13124302","article-title":"Vitamin D deficiency in patients with diabetes in French Guiana: epidemiology and relation with microvascular and macrovascular complications","volume":"13","author":"Girard","year":"2021","journal-title":"Nutrients"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378725000189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378725000189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T19:47:09Z","timestamp":1742240829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378725000189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0035378725000189"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2025.01.002","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retrospective, descriptive study of acute myelitis in French Guyana","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2025.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}